Ribavirin: Efficacy in the Treatment of Murine Autoimmune Disease
- 25 February 1977
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 195 (4280), 787-789
- https://doi.org/10.1126/science.299957
Abstract
Ribavirin, a drug with known antiviral activity, was given to mice with established lupus nephritis. Ribavirin was effective in prolonging survival, reducing the titer of antibodies to DNA, and reversing proteinuria. Other antiviral agents were not effective in the dosages used.This publication has 13 references indexed in Scilit:
- Antiviral activity of ribavirin on influenza infection in ferretsJournal of Antimicrobial Chemotherapy, 1975
- Viruses and Systemic Lupus ErythematosusNew England Journal of Medicine, 1975
- Effect of l- -D-Ribofuranosyl-l,2,4-Triazole-3-Carboxamide (Ribavirin) on Friend Leukemia Virus Infections in MiceExperimental Biology and Medicine, 1975
- C-type viruses in systemic lupus erythematosusNature, 1974
- THE VIRAL ENVELOPE GLYCOPROTEIN OF MURINE LEUKEMIA VIRUS AND THE PATHOGENESIS OF IMMUNE COMPLEX GLOMERULONEPHRITIS OF NEW ZEALAND MICEThe Journal of Experimental Medicine, 1974
- IMMUNOPATHOGENICITY AND ONCOGENICITY OF MURINE LEUKEMIA VIRUSESThe Journal of Experimental Medicine, 1974
- Drug-Induced Restoration of Cutaneous Delayed Hypersensitivity in Anergic Patients with CancerNew England Journal of Medicine, 1973
- Suppression by 1-β- d -Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) of Influenza Virus-Induced Infections in MiceAntimicrobial Agents and Chemotherapy, 1973
- Broad-Spectrum Antiviral Activity of Virazole: 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamideScience, 1972
- The Immunology and Pathology of NZB MiceAdvances in Immunology, 1968